A “light” touch on PI3K to interrogate cancer drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A “light” touch on PI3K to interrogate cancer drug resistance

Published:2022-11 Issue:11 Volume:29 Page:1573-1575
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Wang Tianlu,Ke Yuepeng,Zhou Yubin

Funder

Cancer Prevention and Research Institute of Texas

National Institutes of Health

Welch Foundation

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference12 articles.

1. Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675;Dronca;Am. J. Clin. Oncol.,2014

2. Optical control of membrane tethering and interorganellar communication at nanoscales;He;Chem. Sci.,2017

3. Optogenetic control of phosphoinositide metabolism;Idevall-hagren;Proc. Natl. Acad. Sci. USA,2012

4. PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers;Liu;Cell Death Dis.,2020

5. Oncogenic role of tumor necrosis factor alpha-induced protein 8 (TNFAIP8);Niture;Cells,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP